Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by adjiane.lab
Group name EquipeAD
Item Type Journal Article
Title MAGI1 inhibits the AMOTL2/p38 stress pathway and prevents luminal breast tumorigenesis
Creator Kantar et al.
Author Diala Kantar
Author Emilie Bousquet Mur
Author Maicol Mancini
Author Vera Slaninova
Author Yezza Ben Salah
Author Luca Costa
Author Elodie Forest
Author Patrice Lassus
Author Charles Géminard
Author Florence Boissière-Michot
Author Béatrice Orsetti
Author Charles Theillet
Author Jacques Colinge
Author Christine Benistant
Author Antonio Maraver
Author Lisa Heron-Milhavet
Author Alexandre Djiane
Abstract Alterations to cell polarization or to intercellular junctions are often associated with epithelial cancer progression, including breast cancers (BCa). We show here that the loss of the junctional scaffold protein MAGI1 is associated with bad prognosis in luminal BCa, and promotes tumorigenesis. E-cadherin and the actin binding scaffold AMOTL2 accumulate in MAGI1 deficient cells which are subjected to increased stiffness. These alterations are associated with low YAP activity, the terminal Hippo-pathway effector, but with an elevated ROCK and p38 Stress Activated Protein Kinase activities. Blocking ROCK prevented p38 activation, suggesting that MAGI1 limits p38 activity in part through releasing actin strength. Importantly, the increased tumorigenicity of MAGI1 deficient cells is rescued in the absence of AMOTL2 or after inhibition of p38, demonstrating that MAGI1 acts as a tumor-suppressor in luminal BCa by inhibiting an AMOTL2/p38 stress pathway.
Publication Scientific Reports
Volume 11
Issue 1
Pages 5752
Date 2021-03-11
Journal Abbr Sci Rep
Language eng
DOI 10.1038/s41598-021-85056-1
ISSN 2045-2322
Library Catalog PubMed
Extra PMID: 33707576
Tags arc, cnrs, fdf, first-last-corresponding, gso, ligue, original, phd, postdoc, top
Date Added 2021/03/15 - 12:22:27
Date Modified 2024/09/30 - 01:34:55
Notes and Attachments PubMed entry (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés